Please try another search
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company’s lead product candidate is AT-007 (also called govorestat) that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It also develops AT-001 (also called caficrestat) that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Name | Age | Since | Title |
---|---|---|---|
Lawrence Steinman | 76 | - | Member of Scientific Advisory Board |
Gregg W. Stone | 67 | - | Member of Scientific Advisory Board |
Teena L. Lerner | 66 | 2017 | Lead Independent Director |
Donald J. D'Amico | - | - | Member of Scientific Advisory Board |
Roy Lester Freeman | 71 | - | Member of Scientific Advisory Board |
Shoshana Shendelman | 45 | 2016 | Chair of the Board of Directors, Founder, President, CEO & Secretary |
Jay S. Skyler | 77 | 2019 | Independent Director |
Stacy J. Kanter | 65 | 2019 | Independent Director |
Roxana Mehran | - | - | Member of Scientific Advisory Board |
Les D. Funtleyder | 53 | 2016 | CFO, Principal Financial Officer & Independent Director |
Donald W. Landry | 69 | - | Chairman of Scientific Advisory Board |
Joel S. Marcus | 77 | 2017 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review